Navigation Links
Howard Leonhardt to Present 25 Years of Experience With Stem Cell Transplantation at 28th Annual Interventional Cardiology Conference in Snowmass, Colo., on March 28
Date:3/26/2013

. Bioheart and Leonhardt Ventures have supported close to 40% of this total.
  • Pre-treating scar with microRNAs, stromal cell-derived factor-1 (SDF-1) and hydrogel can improve results.
  • Genetically modifying cells to over-express SDF-1 can double improvement results and the consistency of results. Myoblasts alone lead to 27% improvement, while SDF-1 myoblasts result in 54% improvement. 66% of patients received substantial new muscle formation with SDF-1 myoblasts compared to 33% with ordinary myoblasts.
  • New muscle formed with myoblasts is stretch-activated.
  • Injected cardiac stem cells or induced pluripotent stem (iPS) cells at the rim edge of scar and myoblasts in the center of scar in combination may be worth studying.
  • Electrical stimulation before, during and after stem-cell transplantation can dramatically improve results.
  • Nutrient hydrogel can help improve myoblast cell engraftment in scar tissue.
  • Repeat injection sessions can dramatically improve results. It is believed now up to 36 sessions of percutaneous injections of 300 million cells each may be needed for full myocardial scar recovery.
  • For more information on the 28th Annual International Symposium of Interventional Cardiology, see http://www.interventionalcardiol.com. To learn more about Bioheart's advances in regenerative medicine, visit http://www.bioheartinc.com.

    About Leonhardt Ventures: Since 1983 Leonhardt Ventures http://www.leonhardtventures.com has a strong history of inventing, developing, backing and bringing to market leadership products for treating heart and cardiovascular disease. Over 200,000 patients have been treated to date with Leonhardt inventions. In the 1980s, the group developed market leadership in patented polyurethane balloon catheters includ
    '/>"/>

    SOURCE Bioheart, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
    2. Nektar Therapeutics President and CEO, Howard W. Robin, To Present at the UBS 2012 Global Life Sciences Conference in New York City
    3. Ari Fleischer and Howard Dean to Debate at Beckers 19th Annual Ambulatory Surgery Centers Conference
    4. Carl Icahn Issues Letter To Howard Solomon Of Forest Laboratories
    5. Nektar Therapeutics President and CEO Howard W. Robin to Present at the Jefferies 2012 Global Healthcare Conference in New York
    6. GlySure CEO to Present ICU Trial Results at Spring Medtech Industry Conferences
    7. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
    8. Upsher-Smith Presents Data Supporting Favorable Tolerability And Consistent Pharmacokinetic Profile Of Once-Daily USL255 (Extended-Release Topiramate)
    9. Plato BioPharma Presenting Preclinical capabilities at PKPD Summit Boston
    10. OncoSec Medical to Present at the HemOnc Today Melanoma and Cutaneous Malignancies Meeting in New York
    11. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... 19, 2014 The American Association for Homecare ... and Manufacturing has joined the AAHomecare Corporate Partner Program. ... Diamond have been actively involved in AAHomecare for ... has quickly grown into a major global manufacturer of ... allows AAHomecare to increase efforts on behalf of the ...
    (Date:9/19/2014)... 19, 2014 Larry J. Merlo , President ... will speak before the National Press Club in ... recent move to stop selling tobacco products and its leadership ... health. "Dramatic changes in our health care system ... government," Merlo has said. "CVS Health has a truly unique ...
    (Date:9/19/2014)... Sept. 19, 2014  Lpath, Inc. (NASDAQ: ... lipid-targeted therapeutics, announced today that it has entered ... of common stock and 3,605,042 unregistered warrants in ... for one registered share of common stock and ... of common stock will be $3.475.  The warrants ...
    Breaking Medicine Technology:Drive Medical Design & Manufacturing Joins AAHomecare Corporate Partner Program 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 2CVS Health CEO to Address National Press Club on Landmark Decision to Quit Tobacco, Leadership in Health Care Innovation 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
    (Date:9/21/2014)... While public health authorities focus on the physical activity ... University of Montreal reveals that for children, playing has ... an activity that is fun, done alone or with ... or pleasure, but also to combat boredom, sadness, fear, ... of play, authorities put aside several aspects of play ...
    (Date:9/21/2014)... Expert witness work is in! That ... its 2014 Expert Witness Fees & Practices Survey. With ... and compensation for qualified and credentialed expert witnesses has ... history. , The nearly 600 experts surveyed reported ... work, an increase of 3.2% from ExpertPages’ 2012 survey. ...
    (Date:9/21/2014)... 2014 The asthma market saw ... it has become saturated with relatively efficacious standard ... (ICSs), inhaled corticosteroids and long-acting beta-agonists (ICS/LABAs), and ... generic competition. However, the launch of seven novel ... therapies delivered by the next-generation inhalers will strongly ...
    (Date:9/21/2014)... September 21, 2014 The Electronic ... and supports electronic medical records (EMR) and electronic ... federal healthcare legislation during the past five years ... during the five years to 2019. The 2009 ... Act established Medicare and Medicaid incentives to encourage ...
    (Date:9/21/2014)... Market Research Report on ... 2009-2019 is a professional and in-depth market ... 49562-28-9) industry. The report firstly reviews the ... its classification, application and manufacturing technology.The report ... of Fenofibrate (CAS 49562-28-9) listing their product ...
    Breaking Medicine News(10 mins):Health News:Narrow focus on physical activity could be ruining kids' playtime 2Health News:ExpertPages 2014 Survey Reports Expert Witness Hourly Fees Record All-Time Highs as Demand for Qualified Experts Continues to Grow 2Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Spiriva Asthma Market (Tiotropium Bromide) Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Electronic Medical Records Systems in the US Industry Market Research Report Now Available from IBISWorld 4Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 2Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 3Health News:Fenofibrate Industry Global and Chinese Analysis for 2014-2019 Now Available at LifeScienceIndustryResearch.com 4
    ... Medicare Strike Force Since March, WASHINGTON, Oct. 4 ... and operator of Direct Nursing Assistance Inc. of,Medicare fraud, ... and U.S. Attorney R. Alexander Acosta of the Southern ... trial, Rodolfo Aenlle, 47, was found guilty on all,counts ...
    ... IRIDEX,Corporation (Nasdaq: IRIX ) announced the ... the Company,s new independent auditor effective October,2, 2007. ... by the Audit Committee of the Company,s Board ... discussions with several,public accounting firms. BPM replaces PricewaterhouseCoopers ...
    ... in September Proving Successful, OWINGS MILLS, Md., Oct. ... that based on the current business outlook, the,Company is ... 31,2007. The Company expects to report revenue of $81 ... per diluted share. Previously, the Company,expected to report revenue ...
    ... part of what is ... nonprofit for teens., WILSONVILLE, Ore., Oct. 4 On Tuesday, October ... furniture,arcade games and supplies. These and other items, unused for at least ... the,Sexual Minority Youth Resource Center (SMYRC). Volunteer crews will move an ...
    ... Oct. 4 - A new American Heart,Association survey (1) shows consumer awareness ... an all-time high. But consumers still need,some key information to improve how ... the Bad Fats Are The survey shows that:, --While 92 ... jump from 84 percent in 2006 - only 21 percent ...
    ... revealing how toxic chemicals disrupt gene activity and other ... -- and why some individuals are particularly vulnerable. For ... more likely to experience side effects from certain medications, ... , How can this type of research -- known ...
    Cached Medicine News:Health News:Miami Jury Convicts Medical Company Owner of Medicare Fraud 2Health News:Medifast Announces Updated Full Year 2007 Guidance 2Health News:Medifast Announces Updated Full Year 2007 Guidance 3Health News:Medifast Announces Updated Full Year 2007 Guidance 4Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 2Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 3Health News:Americans' Knowledge of Fats Growing But Still Insufficient 2Health News:Americans' Knowledge of Fats Growing But Still Insufficient 3
    ... 900 offers three magnifications and ... practice, the BP 900 has ... progressive functionality. Two optional beam ... for digital photography, are available ...
    ... it all possible,Open. Automated. Accurate., ,The ... automated multi-purpose instrument that facilitates detection ... the analysis of Single Nucleotide Polymorphisms ... using the NanoChip Electronic Microarray. The ...
    Cable connections for 5 different adapters: Storz, ACMI, Pentax, Wolf and Olympus....
    The Properdin ELISA Kit is approved for in-vitro diagnostic use and measurement of properdin serum levels, relevant in cases of recurrent meningococcal infection and recurrent bacterial meningitis....
    Medicine Products: